FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4364352123> ?p ?o ?g. }

• W4364352123 endingPage "203" @default.
• W4364352123 startingPage "195" @default.
• W4364352123 abstract "BACKGROUND: Rates of venous thromboembolism (VTE) remain high in emergency general surgery (EGS) patients despite chemical VTE prophylaxis. Emerging literature supports anti-factor Xa (AFXa) monitoring for patients on enoxaparin (LMWH), although a significant knowledge gap remains regarding the optimal dosing and monitoring in EGS patients. We hypothesize that standard dose VTE prophylaxis regimens provide inadequate VTE prophylaxis in EGS patients. STUDY DESIGN: A prospective cohort study of all adult EGS patients at a single institution between August 2021 and February 2022 receiving standard dose LMWH for VTE prophylaxis was performed. AFXa levels were obtained 4 hours after the third dose of enoxaparin with a target range of 0.3 to 0.5 IU/mL. Adjustment to dosing and repeat AFXa measurement after the adjusted third dose was obtained. RESULTS: A total of 81 patients underwent AFXa monitoring, the majority (75%) of whom were started on 40 mg LMWH daily. Initial peak AFXa measurement was low in 87.7% of patients (mean 0.16 IU/mL). Of patients who had an initial low AFXa, remained admitted, and underwent dosing adjustment and AFXa reassessment (27%), the majority were adjusted to either 30 or 40 mg of LMWH twice daily (23.7% and 55%, respectively), with 82% of patients remaining low. There were no significant differences in demographics or BMI between those with low vs adequate AFXa levels at either initial or subsequent measurement. CONCLUSIONS: Standard LMWH dosing provides inadequate AFXa inhibition for adequate VTE prophylaxis. These findings highlight the importance of ongoing AFXa monitoring and the need to establish clinical protocols to improve VTE prophylaxis in EGS patients." @default.
• W4364352123 created "2023-04-12" @default.
• W4364352123 creator A5007123234 @default.
• W4364352123 creator A5010272882 @default.
• W4364352123 creator A5024463153 @default.
• W4364352123 creator A5060355695 @default.
• W4364352123 creator A5065162759 @default.
• W4364352123 creator A5082462884 @default.
• W4364352123 creator A5091113469 @default.
• W4364352123 date "2023-04-11" @default.
• W4364352123 modified "2023-09-24" @default.
• W4364352123 title "Anti-Factor Xa Monitoring of Enoxaparin Thromboembolism Prophylaxis in Emergency General Surgery Patients" @default.
• W4364352123 cites W1750582979 @default.
• W4364352123 cites W176762677 @default.
• W4364352123 cites W1970350091 @default.
• W4364352123 cites W1972498313 @default.
• W4364352123 cites W1982740233 @default.
• W4364352123 cites W1991100331 @default.
• W4364352123 cites W2036603576 @default.
• W4364352123 cites W2067738980 @default.
• W4364352123 cites W2083575074 @default.
• W4364352123 cites W2094871265 @default.
• W4364352123 cites W2097567723 @default.
• W4364352123 cites W2142041696 @default.
• W4364352123 cites W2142092434 @default.
• W4364352123 cites W2175097202 @default.
• W4364352123 cites W2286039737 @default.
• W4364352123 cites W2321717601 @default.
• W4364352123 cites W2322068631 @default.
• W4364352123 cites W2331203188 @default.
• W4364352123 cites W2396028391 @default.
• W4364352123 cites W2462315700 @default.
• W4364352123 cites W2507903467 @default.
• W4364352123 cites W2516272876 @default.
• W4364352123 cites W2527983421 @default.
• W4364352123 cites W2567397873 @default.
• W4364352123 cites W2572809378 @default.
• W4364352123 cites W2738176029 @default.
• W4364352123 cites W2744087364 @default.
• W4364352123 cites W2758567736 @default.
• W4364352123 cites W2790760874 @default.
• W4364352123 cites W2794717123 @default.
• W4364352123 cites W2796165711 @default.
• W4364352123 cites W2885320569 @default.
• W4364352123 cites W2932067499 @default.
• W4364352123 cites W2944967372 @default.
• W4364352123 cites W2972871257 @default.
• W4364352123 cites W3009852707 @default.
• W4364352123 cites W3018842916 @default.
• W4364352123 cites W3086705822 @default.
• W4364352123 cites W3195888009 @default.
• W4364352123 cites W4226102495 @default.
• W4364352123 cites W4327857442 @default.
• W4364352123 doi "https://doi.org/10.1097/xcs.0000000000000709" @default.
• W4364352123 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37039364" @default.
• W4364352123 hasPublicationYear "2023" @default.
• W4364352123 type Work @default.
• W4364352123 citedByCount "0" @default.
• W4364352123 crossrefType "journal-article" @default.
• W4364352123 hasAuthorship W4364352123A5007123234 @default.
• W4364352123 hasAuthorship W4364352123A5010272882 @default.
• W4364352123 hasAuthorship W4364352123A5024463153 @default.
• W4364352123 hasAuthorship W4364352123A5060355695 @default.
• W4364352123 hasAuthorship W4364352123A5065162759 @default.
• W4364352123 hasAuthorship W4364352123A5082462884 @default.
• W4364352123 hasAuthorship W4364352123A5091113469 @default.
• W4364352123 hasConcept C126322002 @default.
• W4364352123 hasConcept C141071460 @default.
• W4364352123 hasConcept C144024400 @default.
• W4364352123 hasConcept C149923435 @default.
• W4364352123 hasConcept C188816634 @default.
• W4364352123 hasConcept C2776884760 @default.
• W4364352123 hasConcept C2777288759 @default.
• W4364352123 hasConcept C2777557582 @default.
• W4364352123 hasConcept C2780084366 @default.
• W4364352123 hasConcept C2780868729 @default.
• W4364352123 hasConcept C2991741193 @default.
• W4364352123 hasConcept C2992581537 @default.
• W4364352123 hasConcept C42219234 @default.
• W4364352123 hasConcept C71924100 @default.
• W4364352123 hasConcept C72563966 @default.
• W4364352123 hasConceptScore W4364352123C126322002 @default.
• W4364352123 hasConceptScore W4364352123C141071460 @default.
• W4364352123 hasConceptScore W4364352123C144024400 @default.
• W4364352123 hasConceptScore W4364352123C149923435 @default.
• W4364352123 hasConceptScore W4364352123C188816634 @default.
• W4364352123 hasConceptScore W4364352123C2776884760 @default.
• W4364352123 hasConceptScore W4364352123C2777288759 @default.
• W4364352123 hasConceptScore W4364352123C2777557582 @default.
• W4364352123 hasConceptScore W4364352123C2780084366 @default.
• W4364352123 hasConceptScore W4364352123C2780868729 @default.
• W4364352123 hasConceptScore W4364352123C2991741193 @default.
• W4364352123 hasConceptScore W4364352123C2992581537 @default.
• W4364352123 hasConceptScore W4364352123C42219234 @default.
• W4364352123 hasConceptScore W4364352123C71924100 @default.
• W4364352123 hasConceptScore W4364352123C72563966 @default.
• W4364352123 hasIssue "2" @default.
• W4364352123 hasLocation W43643521231 @default.

• next